Clinical Trial: Lumateperone Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: Schizophrenia
Study Type: INTERVENTIONAL
Official Title: Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Brief Summary:
The main question this study is trying to answer is whether lumateperone, an FDA-approved antipsychotic drug, can help reduce possible side effects of clozapine, such as weight gain and elevated levels of sugar and bad cholesterol.Participants will be randomly assigned to either take lumateperone (Caplyta) or a placebo for 12 weeks, in addition to their regularly prescribed clozapine.During their participation, patients will answer questions about their psychiatric and daily functioning, have blood drawn, and have…
Read more